Proposals Sought for Use of PLCO Data and BiospecimensData and biospecimens from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial are available to qualified researchers through a peer-review process. The Etiology and Early Marker Studies (EEMS) program accepts proposals for access to PLCO biospecimens twice a year. Proposals for the next cycle will be accepted between June 1 and July 16, 2012.
By collecting biologic materials and information about risk factors from trial participants before the diagnosis of disease, EEMS—a component of the PLCO—provides a resource for cancer researchers who are studying the causes and origins of cancer and/or early detection of the disease. Etiologic studies investigate environmental, biochemical, and genetic risk factors for cancer. Early detection studies aim to develop reproducible, reliable biomarkers of early disease.
Details of the review process and application materials are available online . Questions may be directed to email@example.com or 240-314-2313.